Technology
Surprise! Barry McCarthy the CEO of Deluxe, is a proponent of checks as payment tools. Even with the pivot for consumers to digital payment options, business-to-business is still reliant upon an older payment method: checks. Yes, you read that right. Although check usage has decreased significantly since the mid-2000s, physical checks accounted for 42%of B2B transactions in 2019 despite the explosion of digital options.
Read More
In a world where COVID-19 has made on-site collaboration a more and more distant memory — with no end in sight for the growth of remote work as the norm — PaymentsJournal reports: The need for automation has never been more pressing. Clients want quick, efficient solutions that enable them to do more with less. From lending decisions to payments risk management, only technology can provide the necessary support that businesses need.
Read More
Without a doubt, Artificial Intelligence, Deep Learning, Machine Learning, and other technologies are streamlining the revenue cycle management and healthcare payments industries in many different ways. Roni Boker, OrboGraph product manager notes: “Market need still exists, and organizations are now having to move faster than ever with new work environments as a means to implement greater controls on their data and assist with compliance and resiliency.”
Read More
We have receive a tremendous amount of positive feedback from our recent #OrboZone launch, with a countless number of clients, partners, and industry experts raving about their “experience.” But what is #OrboZone? It’s dynamic content that combines high-impact videos, visual galleries, energizing music, and entertaining activities for your WFH environment.
Read More
PNC Bank N.A. announced on Jan. 27 that it has struck a definitive deal to buy payment gateway provider Tempus Technologies, Inc. This new team-up will allow their business customers to handle their receivables and payables via one channel, covering all rails. According to a report at Pymnts.com:
Read More
No one has to tell you the revenue cycle automation process is complex, and getting more so every year. That’s why it’ll come as no surprise that Healthcare Finance News is reporting that about 30% of health systems and hospitals are unable to manage their revenue cycle automation efforts without at least two vendors. The numbers were gathered via the Healthcare Financial Management Association’s Pulse Survey program, fielded between May 19, 2020 and June 22, 2020 among 587 chief financial officers and revenue cycle leaders at various health systems.
Read More
Here’s a paradox we enjoy seeing: Even as it’s proclaimed all over the place that “checks are in decline,” and “checks are alien to Millennials” — we see a forward-looking, technologically innovative payroll infrastructure startup system launch and call itself — Check.
Read More
An article at PaymentsJournal.com cites a 2019 survey by Aite Group indicating that only 18% of banks were at that point moving from a transaction-based revenue model to a data-based approach. While this figure is unlikely to have changed significantly since, PaymentsJournal.com goes on to note that data-driven payments are increasingly on the agenda for banks and we can expect more movement towards this.
Read More
A recent webinar sponsored by Fiserv highlighted reconciliation challenges faced by modern financial institutions as so many consumers adopt digital channels for payments. Fiserv’s 2020 Expectations & Experiences: Consumer Payments survey found that digital payments are indeed on the rise and confidence with virtual payment cards — the Apple Wallet, for instance — is growing.
Read More
Artificial intelligence is already playing a significant role in worldwide healthcare, but Michael Spencer, editor in chief at The Last Futurist, is here to assure you that we haven’t seen anything yet: The complexity and rise of data in healthcare means that artificial intelligence will increasingly be applied within the field. Several types of AI are already being employed by payers and providers of care and life sciences companies. AI is also starting to be used in pharma drug combinations and exploratory combinations and will drive a new era of biotechnology.
Read More